PFE has a similar setup to 
MRNA here, both are attractive buys from a valuation and technical standpoint here and have been beaten down lately due to the situation with rates, banking woes and negative news about COVID vaccines, COVID lock downs, etc. (a general more negative perception of health measures taken by the US govt since 2020 likely part of the reason for the decline here)The companies still have valuable IP and profitable businesses that can rerate higher over time, specially now that the broad market appears to be trending up long term again.
Best of luck!
Cheers,
Ivan Labrie.
Note
Target was hit but there is time left in the signal, a new trend signal can form if this holds up near the target.
🔒Want to dive deeper? Check out my paid services below🔒
linktr.ee/ivanlabrie
linktr.ee/ivanlabrie
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
🔒Want to dive deeper? Check out my paid services below🔒
linktr.ee/ivanlabrie
linktr.ee/ivanlabrie
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.